Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson’s disease with moderate neurodegeneration

The protective impact of exercise on neurodegenerative processes has not been confirmed, and the mechanisms underlying the benefit of exercise have not been determined in human Parkinson’s disease or in chronic animal disease models. This research examined the long‐term neurological, behavioral, and mechanistic consequences of endurance exercise in experimental chronic parkinsonism. We used a chronic 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced mouse model of Parkinson’s disease with moderate neurodegeneration and examined the effects of treadmill exercise on movement and balance coordination, changes in dopamine neuron biomarkers, mitochondrial functions, and neurotrophic factor activities in the nigrostriatal system. The exercise results were compared with those of the control and sedentary chronic parkinsonian animals. After 18 weeks of exercise training in the chronic parkinsonian mice, we observed a significant deterrence in the loss of neuronal dopamine‐producing cells and other functional indicators. The impaired movement and balance incoordination in the chronic parkinsonian mice were also markedly reduced following exercise. Mechanistic investigations revealed that the neuronal and behavioral recovery produced by exercise in the chronic parkinsonian mice was associated with an improved mitochondrial function and an increase in the brain region‐specific levels of brain‐derived and glial cell line‐derived neurotrophic factors. Our findings indicate that exercise not only produces neuronal and mitochondrial protection, it also boosts nigrostriatal neurotrophic factor levels in the chronic parkinsonian mice with moderate neurodegeneration. Therefore, modifying lifestyle with increased exercise activity would be a non‐pharmacological neuroprotective approach for averting neurodegenerative processes, as demonstrated in experimental chronic parkinsonism.

[1]  Christopher G. Goetz,et al.  Physical therapy and Parkinson's disease , 1994, Neurology.

[2]  M. Mattson Neuroprotective signaling and the aging brain: take away my food and let me run 1 1 Published on the World Wide Web on 24 August 2000. , 2000, Brain Research.

[3]  M. Zigmond,et al.  Neuroprotective effects of prior limb use in 6‐hydroxydopamine‐treated rats: possible role of GDNF , 2003, Journal of neurochemistry.

[4]  B. Fisher,et al.  Exercise‐induced behavioral recovery and neuroplasticity in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned mouse basal ganglia , 2004, Journal of neuroscience research.

[5]  E. Hirsch,et al.  Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. , 2003, Human molecular genetics.

[6]  A. Bauman,et al.  Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. , 2007, Circulation.

[7]  B. Hoffer,et al.  Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats , 1998, Experimental Brain Research.

[8]  G. Miller,et al.  Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease , 2003, Neuroscience.

[9]  D. Garris,et al.  Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson’s disease , 2006, Neuroscience.

[10]  M. Beal,et al.  Mitochondria take center stage in aging and neurodegeneration , 2005, Annals of neurology.

[11]  S. Cardoso,et al.  Frontiers in Aging Neuroscience Aging Neuroscience Mitochondrial Dysfunction in the Striatum of Aged Chronic Mouse Model of Parkinson's Disease , 2022 .

[12]  S. Totterdell,et al.  Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson’s disease , 2002, Brain Research.

[13]  M. Zigmond,et al.  Can the brain be protected through exercise? Lessons from an animal model of parkinsonism☆ , 2003, Experimental Neurology.

[14]  C. Cotman,et al.  Exercise: a behavioral intervention to enhance brain health and plasticity , 2002, Trends in Neurosciences.

[15]  R. Drucker-Colín,et al.  A new motor test sensitive to aging and dopaminergic function , 1991, Journal of Neuroscience Methods.

[16]  L. Chia,et al.  Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice , 1998, Neuroscience Letters.

[17]  Max J Kurz,et al.  Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration , 2009, BMC Neuroscience.

[18]  Robert W. Taylor,et al.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.

[19]  Eva Lindqvist,et al.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons , 2007, Proceedings of the National Academy of Sciences.

[20]  L. Stehno-Bittel,et al.  Endurance exercise promotes cardiorespiratory rehabilitation without neurorestoration in the chronic mouse model of Parkinsonism with severe neurodegeneration , 2007, Neuroscience.

[21]  K. Stecker,et al.  Therapeutic value of exercise training in Parkinson's disease. , 2000, Medicine and science in sports and exercise.

[22]  V. Calabrese,et al.  Mitochondrial Involvement in Brain Function and Dysfunction: Relevance to Aging, Neurodegenerative Disorders and Longevity , 2001, Neurochemical Research.

[23]  E. Masliah,et al.  Enhanced substantia nigra mitochondrial pathology in human α-synuclein transgenic mice after treatment with MPTP 1 1 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 2004, Experimental Neurology.

[24]  I. Miyai,et al.  Treadmill training with body weight support: its effect on Parkinson's disease. , 2000, Archives of physical medicine and rehabilitation.

[25]  Jason Eibling Physical Therapy and Parkinsonʼs Disease: A Controlled Clinical Trial , 1995 .

[26]  G. Siegel,et al.  Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain , 2001, Journal of Chemical Neuroanatomy.

[27]  V. Russell,et al.  Voluntary Running Provides Neuroprotection in Rats After 6-Hydroxydopamine Injection into the Medial Forebrain Bundle , 2004, Metabolic Brain Disease.

[28]  田尻 直輝,et al.  Exercise exerts neuroprotective effects on Parkinson's disease model of rats , 2010 .

[29]  Joachim Klose,et al.  Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice* , 2004, Journal of Biological Chemistry.

[30]  E. Hirsch,et al.  Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra. , 1999, Neuroreport.

[31]  M. Beal Oxidatively modified proteins in aging and disease. , 2002, Free radical biology & medicine.

[32]  Fred H. Gage,et al.  Exercise Enhances Learning and Hippocampal Neurogenesis in Aged Mice , 2005, The Journal of Neuroscience.

[33]  Fred H. Gage,et al.  An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus , 2007, Proceedings of the National Academy of Sciences.

[34]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[35]  J S Fowler,et al.  PET studies of the effects of aerobic exercise on human striatal dopamine release. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  S. Dimauro,et al.  A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.

[37]  T. Yagi,et al.  Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder. , 2009, Rejuvenation research.

[38]  G. Muir,et al.  Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats , 2005, Experimental Neurology.

[39]  Bruce A. Yankner,et al.  Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease , 2002, Nature Medicine.

[40]  J. Crampton,et al.  Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. , 1990, General pharmacology.

[41]  Syed O. Ahmad,et al.  Stereologic analysis of cell number and size during postnatal development in the rat substantia nigra , 2007, Neuroscience Letters.

[42]  A. Kelly,et al.  Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. , 2007, Biochemical Society transactions.

[43]  A. Navarro,et al.  Brain mitochondrial dysfunction in aging: conditions that improve survival, neurological performance and mitochondrial function. , 2007, Frontiers in bioscience : a journal and virtual library.

[44]  K. Conley,et al.  Mitochondrial Dysfunction: Impact on Exercise Performance and Cellular Aging , 2007, Exercise and sport sciences reviews.

[45]  L. Novikova,et al.  MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact , 2005, Neuroscience Research.

[46]  T. Sherer,et al.  Mechanistic Approaches to Parkinson's Disease Pathogenesis , 2002, Brain pathology.

[47]  S. Totterdell,et al.  Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment , 2001, Neuroscience.

[48]  G. Donnan,et al.  Reduced BDNF mRNA Expression in the Parkinson's Disease Substantia Nigra , 2000, Experimental Neurology.

[49]  T. Südhof,et al.  Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Effect of exercise on perceived quality of life of individuals with Parkinson's disease. , 2000, Journal of rehabilitation research and development.